June 2025 Calendar Pediatrician – for VCN-01 for the treatment of metastatic pancreatic adenocarcinoma- – Received Rare Pediatric Disease Designation (RPDD) Granted by the U.S. Food and Drug Administration (FDA) for VCN-01 for the . Phase 3 ACTION Study On-Track; First Interim Overall Survival Data Expected Third Quarter 2025 โ โ ONC206 Phase 1 PK […]
